Abivax (ABVX) Capital Expenditures (2024 - 2026)
Abivax (ABVX) posted quarterly Capital Expenditures of -$63220.3 for Q1 2026, down 36.6% year-over-year from -$99709.0 in Q1 2025, and down 127.57% quarter-over-quarter from $229316.6 in Q4 2025.
Abivax (ABVX) Capital Expenditures (2024 - 2026) Analysis & Trends
Abivax's Capital Expenditures history runs 3 years deep, the most recent figure standing at -$63220.3 for Q1 2026.
- In Q1 2026, Capital Expenditures fell 36.6% year-over-year to -$63220.3; the TTM figure through Mar 2026 stood at $153941.5 (down 75.92% YoY), while the FY2025 annual figure was $165294.2, down 75.83% from the prior year.
- Capital Expenditures for Q1 2026 stood at -$63220.3, down from $229316.6 in the prior quarter.
- The five-year high for Capital Expenditures was $1.3 million in Q4 2024, with the low at -$341546.3 in Q3 2024.
- The 3-year median for Capital Expenditures is -$21507.2 (2025), against an average of $86697.3.
- Peak annual rise in Capital Expenditures reached 102.74% in 2025, while the deepest fall reached 255.03% in 2025.
- Abivax's Capital Expenditures stood at $1.3 million in 2024, then tumbled by 81.92% to $229316.6 in 2025, then plunged by 127.57% to -$63220.3 in 2026.
- Business Quant data shows ABVX's Capital Expenditures at -$63220.3 in Q1 2026, $229316.6 in Q4 2025, and $9352.4 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Abivax | 9.39 Bn | 9.39 Bn | - | -63,220.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -63,220.27 |
| Mar 31, 2026 | -63,220.27 |
| Dec 31, 2025 | 229,316.57 |
| Dec 31, 2025 | 229,316.57 |
| Sep 30, 2025 | 9,352.44 |
| Sep 30, 2025 | 9,352.44 |
| Jun 30, 2025 | -21,507.23 |
| Jun 30, 2025 | -21,507.23 |
| Mar 31, 2025 | -46,282.92 |
| Mar 31, 2025 | -46,282.92 |
| Dec 31, 2024 | 1.27 Mn |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | -341,546.27 |
| Sep 30, 2024 | -341,546.27 |
| Jun 30, 2024 | -241,222.82 |
| Jun 30, 2024 | -241,222.82 |
| Mar 31, 2024 | -13,036.34 |
| Mar 31, 2024 | -13,036.34 |